Trial Profile

Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With Idiopathic Osteoporosis (IOP)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Jan 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jan 2023 Results of a preplanned analyses from parent and extension studies (NCT01440803 and NCT02049866) of high-resolution peripheral quantitative computed tomography scans assessing effects on volumetric BMD, microarchitecture, and estimated strength at distal radius and tibia published in the Journal of Bone and Mineral Research
15 Nov 2022 Status changed from active, no longer recruiting to completed.
16 Apr 2022 Results from NCT01440803 and NCT02049866 , defining effects of treatment with teriparatide followed by denosumab on Lumbar Spine (LS) volumetric BMD (vBMD) and stiffness by finite element analysis assessed on central QCT scan, published in the Journal of Clinical Endocrinology and Metabolism

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com